OBJECTIVE: To examine the degree to which disease severity and domains of self-efficacy (pain, function, and other symptoms) explain pain and functioning in rheumatoid arthritis (RA) patients. METHODS: Patients (n = 263) completed the Arthritis Impact Measurement Scales 2 to assess pain and functioning (physical, affective, and social), the Arthritis Self-Efficacy Scale to assess 3 self-efficacy domains (pain, physical function, and other). Disease severity was assessed with C-reactive protein level, physician's rating, and abnormal joint count. Structural equation modeling was used to examine 3 hypotheses: does disease severity have a direct relationship with pain and each area of functioning, does disease severity have a direct relationship with each arthritis self-efficacy domain, and do the self-efficacy domains mediate the relationship between disease severity and RA pain and each area of functioning. RESULTS: Disease severity was related to pain, physical functioning, and each self-efficacy domain (beta = 0.28-0.56, P < 0.001). Each self-efficacy domain was related to its respective domain of functioning (e.g., self-efficacy for pain was related to pain; beta = 0.36-0.54, P < 0.001). Self-efficacy mediated the relationship between disease severity and pain and functioning (beta = 0.12-0.19, P < 0.001). Self-efficacy for pain control and to perform functional tasks accounted for 32-42% of disease severity's total effect on their respective outcomes (e.g., self-efficacy for pain control accounted for 32% of disease severity's total effect on pain). Variance accounted for by the total model was 52% for pain, 53% for physical functioning, and 44% for affective and social functioning. CONCLUSION:Disease severity and self-efficacy both impact RA functioning, and intervening in these areas may lead to better outcomes.
RCT Entities:
OBJECTIVE: To examine the degree to which disease severity and domains of self-efficacy (pain, function, and other symptoms) explain pain and functioning in rheumatoid arthritis (RA) patients. METHODS:Patients (n = 263) completed the Arthritis Impact Measurement Scales 2 to assess pain and functioning (physical, affective, and social), the Arthritis Self-Efficacy Scale to assess 3 self-efficacy domains (pain, physical function, and other). Disease severity was assessed with C-reactive protein level, physician's rating, and abnormal joint count. Structural equation modeling was used to examine 3 hypotheses: does disease severity have a direct relationship with pain and each area of functioning, does disease severity have a direct relationship with each arthritis self-efficacy domain, and do the self-efficacy domains mediate the relationship between disease severity and RA pain and each area of functioning. RESULTS: Disease severity was related to pain, physical functioning, and each self-efficacy domain (beta = 0.28-0.56, P < 0.001). Each self-efficacy domain was related to its respective domain of functioning (e.g., self-efficacy for pain was related to pain; beta = 0.36-0.54, P < 0.001). Self-efficacy mediated the relationship between disease severity and pain and functioning (beta = 0.12-0.19, P < 0.001). Self-efficacy for pain control and to perform functional tasks accounted for 32-42% of disease severity's total effect on their respective outcomes (e.g., self-efficacy for pain control accounted for 32% of disease severity's total effect on pain). Variance accounted for by the total model was 52% for pain, 53% for physical functioning, and 44% for affective and social functioning. CONCLUSION: Disease severity and self-efficacy both impact RA functioning, and intervening in these areas may lead to better outcomes.
Authors: Rebecca A Shelby; Tamara J Somers; Francis J Keefe; Jennifer J Pells; Kim E Dixon; James A Blumenthal Journal: J Pain Date: 2008-07-07 Impact factor: 5.820
Authors: Elif Gür Kabul; Ummuhan Baş Aslan; Bilge Başakçı Çalık; Murat Taşçı; Veli Çobankara Journal: Rheumatol Int Date: 2018-05-30 Impact factor: 2.631
Authors: Cesar Ramos-Remus; José Dionisio Castillo-Ortiz; Carlos Sandoval-Castro; Francisco Paez-Agraz; Adriana Sanchez-Ortiz; Francisco Javier Aceves-Avila Journal: Rheumatol Int Date: 2014-05-24 Impact factor: 2.631
Authors: Joan E Broderick; Doerte U Junghaenel; Stefan Schneider; Patricia Bruckenthal; Francis J Keefe Journal: Clin J Pain Date: 2011-05 Impact factor: 3.442
Authors: Jessica S Merlin; Sarah R Young; Mallory O Johnson; Michael Saag; William Demonte; Riddhi Modi; Sally Shurbaji; William A Anderson; Robert Kerns; Matthew J Bair; Stefan Kertesz; Susan Davies; Janet M Turan Journal: Pain Med Date: 2017-05-01 Impact factor: 3.750